Sign up for our newsletter!

Get the latest information and inspirational stories for caregivers, delivered directly to your inbox.

go back

Second Drug Now Approved for Treating Alzheimer's Patients

Resource Blog

description

Treatment options for patients with Alzheimer’s disease just took a big leap forward with the approval of a second drug, donanemab, that helps patients with early symptomatic Alzheimer’s disease maintain function and quality of life.

See full story at Resource Blog

More Stories From

SCIENCE

description

How Diabetes Quietly Rewires the Brain’s Reward and Memory System

SciTechDaily

description

Pilot Study Suggests Senolytic Medications May Boost Cognition in Alzheimer's Risk Group

Medical Xpress

description

Melatonin Trial in Older Adults With Cognitive Impairment Shows Feasibility, But No Clear Effects Yet

PsyPost

MORE SCIENCE
MCI and Beyond
AboutBlogContactFAQ
YouTubeTwitterFacebookInstagramLinkedIn

© 2025 MCI and Beyond. All rights reserved.